These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Design, Synthesis, and in vitro antitubercular activity of 1,2,3-triazolyl-dihydroquinoline derivatives. Banu S; Bollu R; Nagarapu L; Nanubolu JB; Yogeswari P; Sriram D; Gunda SK; Vardhan D Chem Biol Drug Des; 2018 Jul; 92(1):1315-1323. PubMed ID: 29624868 [TBL] [Abstract][Full Text] [Related]
45. Synthesis and anti-mycobacterial activity of 4-(4-phenyl-1H-1,2,3-triazol-1-yl)salicylhydrazones: revitalizing an old drug. Abdu-Allah HH; Youssif BG; Abdelrahman MH; Abdel-Hamid MK; Reshma RS; Yogeeswari P; Aboul-Fadl T; Sriram D Arch Pharm Res; 2017 Feb; 40(2):168-179. PubMed ID: 28028696 [TBL] [Abstract][Full Text] [Related]
46. Sequential synthesis of amino-1,4-naphthoquinone-appended triazoles and triazole-chromene hybrids and their antimycobacterial evaluation. Devi Bala B; Muthusaravanan S; Choon TS; Ashraf Ali M; Perumal S Eur J Med Chem; 2014 Oct; 85():737-46. PubMed ID: 25129868 [TBL] [Abstract][Full Text] [Related]
47. 4,5-Dihydro-1H-pyrazolo[3,4-d]pyrimidine containing phenothiazines as antitubercular agents. Siddiqui AB; Trivedi AR; Kataria VB; Shah VH Bioorg Med Chem Lett; 2014 Mar; 24(6):1493-5. PubMed ID: 24582983 [TBL] [Abstract][Full Text] [Related]
48. Synthesis and in vitro evaluation of novel substituted isatin-propylene-1H-1,2,3-triazole-4-methylene-moxifloxacin hybrids for their anti-mycobacterial activities. Yan X; Lv Z; Wen J; Zhao S; Xu Z Eur J Med Chem; 2018 Jan; 143():899-904. PubMed ID: 29227930 [TBL] [Abstract][Full Text] [Related]
49. Synthesis of alkynylated 1,2,4-oxadiazole/1,2,3-1H-triazole glycoconjugates: Discovering new compounds for use in chemotherapy against lung carcinoma and Mycobacterium tuberculosis. Melo de Oliveira VN; Flávia do Amaral Moura C; Peixoto ADS; Gonçalves Ferreira VP; Araújo HM; Lapa Montenegro Pimentel LM; Pessoa CDÓ; Nicolete R; Versiani Dos Anjos J; Sharma PP; Rathi B; Pena LJ; Rollin P; Tatibouët A; Nascimento de Oliveira R Eur J Med Chem; 2021 Aug; 220():113472. PubMed ID: 33940463 [TBL] [Abstract][Full Text] [Related]
50. Synthesis and antituberculosis activity of new hydrazide derivatives. Kaplancikli ZA; Turan-Zitouni G; Ozdemir A; Teulade JC Arch Pharm (Weinheim); 2008 Nov; 341(11):721-4. PubMed ID: 18720343 [TBL] [Abstract][Full Text] [Related]
51. Design, Synthesis, and Biological Evaluation of 1,4-dihydropyridine Derivatives as Potent Antitubercular Agents. Desai NC; Trivedi AR; Somani HC; Bhatt KA Chem Biol Drug Des; 2015 Sep; 86(3):370-7. PubMed ID: 25534154 [TBL] [Abstract][Full Text] [Related]
52. Synthesis of some novel thiourea derivatives obtained from 5-[(4-aminophenoxy)methyl]-4-alkyl/aryl-2,4-dihydro-3H-1,2,4-triazole-3-thiones and evaluation as antiviral/anti-HIV and anti-tuberculosis agents. Küçükgüzel I; Tatar E; Küçükgüzel SG; Rollas S; De Clercq E Eur J Med Chem; 2008 Feb; 43(2):381-92. PubMed ID: 17583388 [TBL] [Abstract][Full Text] [Related]
53. Triazole derivatives and their anti-tubercular activity. Zhang S; Xu Z; Gao C; Ren QC; Chang L; Lv ZS; Feng LS Eur J Med Chem; 2017 Sep; 138():501-513. PubMed ID: 28692915 [TBL] [Abstract][Full Text] [Related]
54. Design, synthesis of benzocoumarin-pyrimidine hybrids as novel class of antitubercular agents, their DNA cleavage and X-ray studies. Reddy DS; Hosamani KM; Devarajegowda HC Eur J Med Chem; 2015 Aug; 101():705-15. PubMed ID: 26210508 [TBL] [Abstract][Full Text] [Related]